We found that hypermethylation of the DR4 and DR5 CpG islands is highly associated with a lack of cell-surface expression of DR4 and DR5, and TRAIL resistance in BCP-ALL cell lines. The gene discussed is TNFRSF10A; the disease is acute lymphoblastic leukemia.